Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
A. Prasanth Saraswati(University of Siena), Ähmed Kamal(Osmania University), S.M. Ali Hussaini(Indian Institute of Chemical Technology), Namballa Hari Krishna(National Institute of Pharmaceutical Education and Research - Ahmedabad), Bathini Nagendra Babu(University of Hyderabad)
Cited by 119
Related Papers
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
|Current Medicinal Chemistry|2017|127
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
|Journal of Medicinal Chemistry|2019|115
Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents
|MedChemComm|2017|75
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors
|Journal of Medicinal Chemistry|2021|55
Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials
|Current Topics in Medicinal Chemistry|2020|54